Health Highlights, April 6, 2022

FDA panel meets to craft future COVID vaccine strategy: The panel will hear from experts about whether boosters or new vaccines will be needed going forward. Read more
Biden launches national COVID research initiative: Scientists from numerous federal agencies will examine the nature and impact of long COVID, a constellation of sometimes debilitating symptoms that linger long after infection in nearly one-third of Americans. Read more
Half of Americans are dying with a dementia diagnosis: Still, that increase of 36% from two decades ago may have more to do with better record-keeping than an actual rise in cases, the study authors said. Read more
Israeli study shows second booster dose boosts protection against Omicron: But the researchers also found the shot's power started to wane after four weeks. Read more
Related Posts
Long Targeted in Abortion Battle, U.S. Global AIDS Program Gets New Home in State Department
WEDNESDAY, Aug. 2, 2023 (HealthDay News) -- The President's Emergency Program...
Pfizer Set to Ask FDA to Approve Booster for Those 18 and Older
TUESDAY, Nov. 9, 2021 (HealthDay News) -- Pfizer may soon seek U.S. Food and...
Blood Donors’ Gender Doesn’t Affect Outcomes for Recipients
THURSDAY, April 13, 2023 (HealthDay News) -- Whether the gender of a blood donor...
Racial Differences Seen for Joint Replacement Care and Outcomes
FRIDAY, April 29, 2022 (HealthDay News) -- Racial differences persist across the...
